quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·108d
PRRelease
BillionToOne Inc. logo

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

BLLN· BillionToOne Inc.
Health Care
Original source

Companies

  • BLLN
    BillionToOne Inc.
    Health Care

Recent analyst ratings

  • Jan 6UpdateGuggenheim$120.00
  • Dec 1UpdateWilliam Blair-
  • Dec 1UpdateJefferies$117.00
  • Dec 1UpdateAnalyst$150.00
  • Dec 1UpdatePiper Sandler$150.00
  • Dec 1UpdateStifel$145.00

Related

  • SEC2d
    SEC Form DEFA14A filed by BillionToOne Inc.
  • SEC2d
    SEC Form DEF 14A filed by BillionToOne Inc.
  • PR9d
    BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
  • PR22d
    BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
  • SEC43d
    SEC Form 10-K filed by BillionToOne Inc.
  • SEC50d
    BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
  • PR50d
    BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
  • SEC65d
    SEC Form SCHEDULE 13G filed by BillionToOne Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022